Srs Capital Advisors, Inc. Merck & Co., Inc. Transaction History

Srs Capital Advisors, Inc.

$1.07 Billion
Q3 2024

A detailed history of Srs Capital Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 6,405 shares of MRK stock, worth $636,464. This represents 0.07% of its overall portfolio holdings.

Number of Shares

6,405

Previous 6,148 4.18%

Holding current value

$636,464

Previous $761,000 4.47%

% of portfolio

0.07%

Previous 0.08%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	BUY	$111.15 - $128.97 $28,565 - $33,145	257 Added 4.18%	6,405 $727,000
Q2 2024 Aug 06, 2024	BUY	$123.8 - $132.96 $109,563 - $117,669	885 Added 16.82%	6,148 $761,000
Q1 2024 May 14, 2024	BUY	$113.24 - $131.95 $25,592 - $29,820	226 Added 4.49%	5,263 $694,000
Q4 2023 Feb 06, 2024	BUY	$100.18 - $109.02 $8,114 - $8,830	81 Added 1.63%	5,037 $549,000
Q3 2023 Nov 14, 2023	SELL	$102.95 - $114.33 $11,633 - $12,919	-113 Reduced 2.23%	4,956 $510,000
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $8,906 - $9,707	82 Added 1.64%	5,069 $584,000
Q1 2023 May 16, 2023	SELL	$102.94 - $114.86 $1,852 - $2,067	-18 Reduced 0.36%	4,987 $530,000
Q4 2022 Feb 24, 2023	BUY	$87.44 - $112.11 $38,036 - $48,767	435 Added 9.52%	5,005 $555,000
Q3 2022 Nov 03, 2022	SELL	$84.53 - $94.96 $36,770 - $41,307	-435 Reduced 8.69%	4,570 $394,000
Q2 2022 Aug 22, 2022	BUY	$83.49 - $94.64 $52,515 - $59,528	629 Added 14.37%	5,005 $456,000
Q1 2022 May 12, 2022	SELL	$73.51 - $82.4 $34,917 - $39,140	-475 Reduced 9.79%	4,376 $359,000
Q4 2021 Feb 08, 2022	BUY	$72.28 - $90.54 $289 - $362	4 Added 0.08%	4,851 $372,000
Q3 2021 Nov 05, 2021	BUY	$71.68 - $78.83 $74,905 - $82,377	1,045 Added 27.49%	4,847 $364,000
Q2 2021 Aug 02, 2021	BUY	$70.31 - $77.77 $44,154 - $48,839	628 Added 19.79%	3,802 $296,000
Q4 2020 Feb 03, 2021	BUY	$71.77 - $79.65 $7,751 - $8,602	108 Added 3.52%	3,174 $260,000
Q3 2020 Nov 12, 2020	SELL	$73.18 - $82.95 $121,405 - $137,614	-1,659 Reduced 35.11%	3,066 $254,000
Q2 2020 Aug 06, 2020	BUY	$70.42 - $80.13 $352 - $400	5 Added 0.11%	4,725 $365,000
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $11,024 - $15,280	174 Added 3.83%	4,720 $363,000
Q4 2019 Feb 07, 2020	SELL	$77.58 - $87.54 $9,619 - $10,854	-124 Reduced 2.66%	4,546 $413,000
Q3 2019 Nov 01, 2019	BUY	$76.08 - $82.93 $228 - $248	3 Added 0.06%	4,670 $393,000
Q2 2019 Aug 08, 2019	BUY	$69.84 - $81.59 $40,297 - $47,077	577 Added 14.11%	4,667 $391,000
Q4 2018 Feb 06, 2019	BUY	$65.24 - $75.71 $91,205 - $105,842	1,398 Added 51.93%	4,090 $312,000
Q3 2018 Nov 06, 2018	BUY	$57.69 - $67.84 $31,094 - $36,565	539 Added 25.03%	2,692 $191,000
Q2 2018 Aug 21, 2018	BUY	$50.83 - $59.72 $8,641 - $10,152	170 Added 8.57%	2,153 $130,000
Q1 2018 May 14, 2018	BUY	$50.96 - $59.23 $68,286 - $79,368	1,340 Added 208.4%	1,983 $108,000
Q4 2017 Feb 15, 2018	SELL	$51.62 - $61.64 $41,502 - $49,558	-804 Reduced 55.56%	643 $36,000
Q3 2017 Nov 15, 2017	BUY	$58.67 - $63.13 $84,895 - $91,349	1,447	1,447 $92,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $252B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Srs Capital Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Srs Capital Advisors, Inc. with notifications on news.

Account

Srs Capital Advisors, Inc. Merck & Co., Inc. Transaction History